Ashleigh Dennis

This special audio release for Mental Health Awareness Month explores the human impact of systemic failures across public health, mental health, and social support systems. Grounded in lived experience, the conversation surfaces how grief, addiction, and loss are too often met with stigma, institutional inaction, and a lack of coordinated care. It’s a reminder that public health is not just about systems and services—it’s about people, and the urgent need to center compassion and accountability in how those systems respond to crisis. Trigger warning: This episode includes sensitive topics around grief and addiction.

The "War on Drugs" led to many drug paraphernalia laws that are still in effect nearly fifty years later. By repealing drug paraphernalia laws, which criminalize people who use drugs and lead to increased health and racial disparities in incarceration, jurisdictions can focus on evidence-based, common-sense approaches that respect the dignity and autonomy of people who use drugs.

Contaminants including fentanyl and fentanyl analogs are now present in the illicit drug supply throughout the U.S. Because no safe supply of most illicitly used drugs is available, helping people determine what is in the drugs they obtain can be an impactful harm reduction intervention. The easiest and most inexpensive way to accomplish this is often through use of fentanyl test strips and xylazine test strips. This resource outlines the legality of drug checking equipment in 50 states and the District of Columbia.

In recognition of Mental Health Awareness Month, Network attorneys and staff have identified six key policies with the potential to significantly improve mental health outcomes across the United States. This policy brief covers a wide range of areas focused on communities and those who work to support communities. It is designed as a practical resource for public health professionals, leaders, and partners, offering strategies to enhance mental health and well-being while reducing disparities in mental health care.

This fact sheet provides information on Pennsylvania's Act 139, which provides limited immunity to overdose victims and bystanders that seek medical help, and increases accesss to naloxone, a drug that can reverse the effects of an opioid overdose.

Syringe services programs (SSPs) are crucial legal and health intervention and multiple studies have shown the best model for SSPs is needs-based syringe distribution, in which SSP participants are provided with the quantity of supplies they need to use safely. Yet, many states require participants to return a used needle for every new needle they are given, resulting in undue health risks and other harms.

This survey of state laws outlines how the legal landscape in each state may affect access to harm reduction services and supplies.

In the U.S. there is considerable variation in the presence and specifics of laws regarding drug paraphernalia, naloxone access, and protections for people who call for help in an overdose, and these laws have changed over time. This webinar is designed to reduce confusion around harm reduction laws in the U.S. and help individuals and organizations better understand how the legal landscape in their state may impact access to harm reduction services and supplies and emergency medical assistance in an overdose.

Over one million people in the U.S. have died from overdose since 1999. This year, as we remember those we’ve needlessly lost, we are also seeing calls for increased penalties for people who share drugs. Perhaps the cruelest form of these laws are drug-induced homicide (“DIH”) laws.

The “War on Drugs” could better be described as a “War on People.” In addition to obvious negative impacts such as incarceration and increases in drug-related harm, this “War” also leads to collateral consequences that can last for years —or even a lifetime. Collateral consequences are legal barriers resulting from a person’s conviction in addition to incarceration, parole or probation, and fines and fees.